Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Index by author

May 01, 1990; Volume 37,Issue 5
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Abel, M S

    1. You have access
      Differential expression of gamma-aminobutyric acidA receptor subunits.
      K M Garrett, N Saito, R S Duman, M S Abel, R A Ashton, S Fujimori, B Beer, J F Tallman, M P Vitek and A J Blume
      Molecular Pharmacology May 1990, 37 (5) 652-657;
  2. Ashmun, R

    1. You have access
      Relationship of deoxynucleotide changes to inhibition of DNA synthesis induced by the antiretroviral agent 3'-azido-3'-deoxythymidine and release of its monophosphate by human lymphoid cells (CCRF-CEM).
      A Fridland, M C Connelly and R Ashmun
      Molecular Pharmacology May 1990, 37 (5) 665-670;
  3. Ashton, R A

    1. You have access
      Differential expression of gamma-aminobutyric acidA receptor subunits.
      K M Garrett, N Saito, R S Duman, M S Abel, R A Ashton, S Fujimori, B Beer, J F Tallman, M P Vitek and A J Blume
      Molecular Pharmacology May 1990, 37 (5) 652-657;
  4. Aylwin, M

    1. You have access
      Niflumic and flufenamic acids are potent reversible blockers of Ca2(+)-activated Cl- channels in Xenopus oocytes.
      M M White and M Aylwin
      Molecular Pharmacology May 1990, 37 (5) 720-724;

B

  1. Beer, B

    1. You have access
      Differential expression of gamma-aminobutyric acidA receptor subunits.
      K M Garrett, N Saito, R S Duman, M S Abel, R A Ashton, S Fujimori, B Beer, J F Tallman, M P Vitek and A J Blume
      Molecular Pharmacology May 1990, 37 (5) 652-657;
  2. Bernaerts, R

    1. You have access
      Mechanism of action of 5-(2-chloroethyl)-2'-deoxyuridine, a selective inhibitor of herpes simplex virus replication.
      E De Clercq, R Bernaerts, A Merta and B Rosenwirth
      Molecular Pharmacology May 1990, 37 (5) 658-664;
  3. Blume, A J

    1. You have access
      Differential expression of gamma-aminobutyric acidA receptor subunits.
      K M Garrett, N Saito, R S Duman, M S Abel, R A Ashton, S Fujimori, B Beer, J F Tallman, M P Vitek and A J Blume
      Molecular Pharmacology May 1990, 37 (5) 652-657;
  4. Bogucki, B D

    1. You have access
      Stereoselective sulfoxidation of a series of alkyl p-tolyl sulfides by microsomal and purified flavin-containing monooxygenases.
      A E Rettie, B D Bogucki, I Lim and G P Meier
      Molecular Pharmacology May 1990, 37 (5) 643-651;
  5. Borislow, S

    1. You have access
      Solubilization of active somatostatin receptors from rat brain.
      H T He, S Rens-Domiano, J M Martin, S F Law, S Borislow, M Woolkalis, D Manning and T Reisine
      Molecular Pharmacology May 1990, 37 (5) 614-621;
  6. Brodersen, R

    1. You have access
      Valproate and palmitate binding to human serum albumin: an hypothesis on obesity.
      R Brodersen, N Jørgensen, H Vorum and N Krukow
      Molecular Pharmacology May 1990, 37 (5) 704-709;
  7. Bruno, V

    1. You have access
      Specific binding sites for inositolhexakisphosphate in brain and anterior pituitary.
      F Nicoletti, V Bruno, S Cavallaro, A Copani, M A Sortino and P L Canonico
      Molecular Pharmacology May 1990, 37 (5) 689-693;
  8. Brush, K

    1. You have access
      Ryanodine as a probe for the functional state of the skeletal muscle sarcoplasmic reticulum calcium release channel.
      A Chu, M Díaz-Muñoz, M J Hawkes, K Brush and S L Hamilton
      Molecular Pharmacology May 1990, 37 (5) 735-741;

C

  1. Canonico, P L

    1. You have access
      Specific binding sites for inositolhexakisphosphate in brain and anterior pituitary.
      F Nicoletti, V Bruno, S Cavallaro, A Copani, M A Sortino and P L Canonico
      Molecular Pharmacology May 1990, 37 (5) 689-693;
  2. Cavallaro, S

    1. You have access
      Specific binding sites for inositolhexakisphosphate in brain and anterior pituitary.
      F Nicoletti, V Bruno, S Cavallaro, A Copani, M A Sortino and P L Canonico
      Molecular Pharmacology May 1990, 37 (5) 689-693;
  3. Chu, A

    1. You have access
      Ryanodine as a probe for the functional state of the skeletal muscle sarcoplasmic reticulum calcium release channel.
      A Chu, M Díaz-Muñoz, M J Hawkes, K Brush and S L Hamilton
      Molecular Pharmacology May 1990, 37 (5) 735-741;
  4. Connelly, M C

    1. You have access
      Relationship of deoxynucleotide changes to inhibition of DNA synthesis induced by the antiretroviral agent 3'-azido-3'-deoxythymidine and release of its monophosphate by human lymphoid cells (CCRF-CEM).
      A Fridland, M C Connelly and R Ashmun
      Molecular Pharmacology May 1990, 37 (5) 665-670;
  5. Conner, D A

    1. You have access
      Serotonin receptor-mediated activation of adenylate cyclase in the neuroblastoma NCB.20: a novel 5-hydroxytryptamine receptor.
      D A Conner and T E Mansour
      Molecular Pharmacology May 1990, 37 (5) 742-751;
  6. Copani, A

    1. You have access
      Specific binding sites for inositolhexakisphosphate in brain and anterior pituitary.
      F Nicoletti, V Bruno, S Cavallaro, A Copani, M A Sortino and P L Canonico
      Molecular Pharmacology May 1990, 37 (5) 689-693;
  7. Crippen, G M

    1. You have access
      Modeling the benzodiazepine receptor binding site by the general three-dimensional structure-directed quantitative structure-activity relationship method REMOTEDISC.
      A K Ghose and G M Crippen
      Molecular Pharmacology May 1990, 37 (5) 725-734;

D

  1. De Clercq, E

    1. You have access
      Mechanism of action of 5-(2-chloroethyl)-2'-deoxyuridine, a selective inhibitor of herpes simplex virus replication.
      E De Clercq, R Bernaerts, A Merta and B Rosenwirth
      Molecular Pharmacology May 1990, 37 (5) 658-664;
  2. Díaz-Muñoz, M

    1. You have access
      Ryanodine as a probe for the functional state of the skeletal muscle sarcoplasmic reticulum calcium release channel.
      A Chu, M Díaz-Muñoz, M J Hawkes, K Brush and S L Hamilton
      Molecular Pharmacology May 1990, 37 (5) 735-741;
  3. Dirksen, R T

    1. You have access
      Antipsychotic pimozide is a potent Ca2+ channel blocker in heart.
      J J Enyeart, R T Dirksen, V K Sharma, D J Williford and S S Sheu
      Molecular Pharmacology May 1990, 37 (5) 752-757;
  4. Doehmer, J

    1. You have access
      Stable expression of rat cytochrome P-450IA1 cDNA in V79 Chinese hamster cells and their use in mutagenicity testing.
      S Dogra, J Doehmer, H Glatt, H Mölders, P Siegert, T Friedberg, A Seidel and F Oesch
      Molecular Pharmacology May 1990, 37 (5) 608-613;
  5. Dogra, S

    1. You have access
      Stable expression of rat cytochrome P-450IA1 cDNA in V79 Chinese hamster cells and their use in mutagenicity testing.
      S Dogra, J Doehmer, H Glatt, H Mölders, P Siegert, T Friedberg, A Seidel and F Oesch
      Molecular Pharmacology May 1990, 37 (5) 608-613;
  6. Duman, R S

    1. You have access
      Differential expression of gamma-aminobutyric acidA receptor subunits.
      K M Garrett, N Saito, R S Duman, M S Abel, R A Ashton, S Fujimori, B Beer, J F Tallman, M P Vitek and A J Blume
      Molecular Pharmacology May 1990, 37 (5) 652-657;

E

  1. Enyeart, J J

    1. You have access
      Antipsychotic pimozide is a potent Ca2+ channel blocker in heart.
      J J Enyeart, R T Dirksen, V K Sharma, D J Williford and S S Sheu
      Molecular Pharmacology May 1990, 37 (5) 752-757;
  2. Evans, W E

    1. You have access
      Xbal 16- plus 9-kilobase DNA restriction fragments identify a mutant allele for debrisoquin hydroxylase: report of a family study.
      W E Evans and M V Relling
      Molecular Pharmacology May 1990, 37 (5) 639-642;

F

  1. Farb, D H

    1. You have access
      Inverse modulation of gamma-aminobutyric acid- and glycine-induced currents by progesterone.
      F S Wu, T T Gibbs and D H Farb
      Molecular Pharmacology May 1990, 37 (5) 597-602;
    2. You have access
      gamma-Aminobutyric acidA receptor regulation in culture: altered allosteric interactions following prolonged exposure to benzodiazepines, barbiturates, and methylxanthines.
      D J Roca, G D Schiller, L Friedman, I Rozenberg, T T Gibbs and D H Farb
      Molecular Pharmacology May 1990, 37 (5) 710-719;
  2. Fridland, A

    1. You have access
      Relationship of deoxynucleotide changes to inhibition of DNA synthesis induced by the antiretroviral agent 3'-azido-3'-deoxythymidine and release of its monophosphate by human lymphoid cells (CCRF-CEM).
      A Fridland, M C Connelly and R Ashmun
      Molecular Pharmacology May 1990, 37 (5) 665-670;
  3. Friedberg, T

    1. You have access
      Stable expression of rat cytochrome P-450IA1 cDNA in V79 Chinese hamster cells and their use in mutagenicity testing.
      S Dogra, J Doehmer, H Glatt, H Mölders, P Siegert, T Friedberg, A Seidel and F Oesch
      Molecular Pharmacology May 1990, 37 (5) 608-613;
  4. Friedman, L

    1. You have access
      gamma-Aminobutyric acidA receptor regulation in culture: altered allosteric interactions following prolonged exposure to benzodiazepines, barbiturates, and methylxanthines.
      D J Roca, G D Schiller, L Friedman, I Rozenberg, T T Gibbs and D H Farb
      Molecular Pharmacology May 1990, 37 (5) 710-719;
  5. Frusciante, M J

    1. You have access
      Rat brain N-methyl-D-aspartate receptors require multiple molecules of agonist for activation.
      D C Javitt, M J Frusciante and S R Zukin
      Molecular Pharmacology May 1990, 37 (5) 603-607;
  6. Fujimori, S

    1. You have access
      Differential expression of gamma-aminobutyric acidA receptor subunits.
      K M Garrett, N Saito, R S Duman, M S Abel, R A Ashton, S Fujimori, B Beer, J F Tallman, M P Vitek and A J Blume
      Molecular Pharmacology May 1990, 37 (5) 652-657;

G

  1. Garrett, K M

    1. You have access
      Differential expression of gamma-aminobutyric acidA receptor subunits.
      K M Garrett, N Saito, R S Duman, M S Abel, R A Ashton, S Fujimori, B Beer, J F Tallman, M P Vitek and A J Blume
      Molecular Pharmacology May 1990, 37 (5) 652-657;
  2. Ghose, A K

    1. You have access
      Modeling the benzodiazepine receptor binding site by the general three-dimensional structure-directed quantitative structure-activity relationship method REMOTEDISC.
      A K Ghose and G M Crippen
      Molecular Pharmacology May 1990, 37 (5) 725-734;
  3. Gibbs, T T

    1. You have access
      Inverse modulation of gamma-aminobutyric acid- and glycine-induced currents by progesterone.
      F S Wu, T T Gibbs and D H Farb
      Molecular Pharmacology May 1990, 37 (5) 597-602;
    2. You have access
      gamma-Aminobutyric acidA receptor regulation in culture: altered allosteric interactions following prolonged exposure to benzodiazepines, barbiturates, and methylxanthines.
      D J Roca, G D Schiller, L Friedman, I Rozenberg, T T Gibbs and D H Farb
      Molecular Pharmacology May 1990, 37 (5) 710-719;
  4. Gierschik, P

    1. You have access
      Pseudomonas exotoxin A prevents beta-adrenoceptor-induced upregulation of Gi protein alpha-subunits and adenylyl cyclase desensitization in rat heart muscle cells.
      C Reithmann, P Gierschik, U Müller, K Werdan and K H Jakobs
      Molecular Pharmacology May 1990, 37 (5) 631-638;
  5. Gies, J P

    1. You have access
      Sialic acid residues as catalysts for M2-muscarinic agonist-receptor interactions.
      E B Haddad, Y Landry and J P Gies
      Molecular Pharmacology May 1990, 37 (5) 682-688;
  6. Glatt, H

    1. You have access
      Stable expression of rat cytochrome P-450IA1 cDNA in V79 Chinese hamster cells and their use in mutagenicity testing.
      S Dogra, J Doehmer, H Glatt, H Mölders, P Siegert, T Friedberg, A Seidel and F Oesch
      Molecular Pharmacology May 1990, 37 (5) 608-613;

H

  1. Haddad, E B

    1. You have access
      Sialic acid residues as catalysts for M2-muscarinic agonist-receptor interactions.
      E B Haddad, Y Landry and J P Gies
      Molecular Pharmacology May 1990, 37 (5) 682-688;
  2. Hamilton, S L

    1. You have access
      Ryanodine as a probe for the functional state of the skeletal muscle sarcoplasmic reticulum calcium release channel.
      A Chu, M Díaz-Muñoz, M J Hawkes, K Brush and S L Hamilton
      Molecular Pharmacology May 1990, 37 (5) 735-741;
  3. Haslam, R J

    1. You have access
      Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
      D H Maurice and R J Haslam
      Molecular Pharmacology May 1990, 37 (5) 671-681;
  4. Hawkes, M J

    1. You have access
      Ryanodine as a probe for the functional state of the skeletal muscle sarcoplasmic reticulum calcium release channel.
      A Chu, M Díaz-Muñoz, M J Hawkes, K Brush and S L Hamilton
      Molecular Pharmacology May 1990, 37 (5) 735-741;
  5. He, H T

    1. You have access
      Solubilization of active somatostatin receptors from rat brain.
      H T He, S Rens-Domiano, J M Martin, S F Law, S Borislow, M Woolkalis, D Manning and T Reisine
      Molecular Pharmacology May 1990, 37 (5) 614-621;
  6. Hooper, W D

    1. You have access
      Cytochrome P450IIIA enzymes in rat liver microsomes: involvement in C3-hydroxylation of diazepam and nordazepam but not N-dealkylation of diazepam and temazepam.
      P E Reilly, D A Thompson, S R Mason and W D Hooper
      Molecular Pharmacology May 1990, 37 (5) 767-774;

I

  1. Ivins, K J

    1. You have access
      Serotonin-2 receptors coupled to phosphoinositide hydrolysis in a clonal cell line.
      K J Ivins and P B Molinoff
      Molecular Pharmacology May 1990, 37 (5) 622-630;

J

  1. Jakobs, K H

    1. You have access
      Pseudomonas exotoxin A prevents beta-adrenoceptor-induced upregulation of Gi protein alpha-subunits and adenylyl cyclase desensitization in rat heart muscle cells.
      C Reithmann, P Gierschik, U Müller, K Werdan and K H Jakobs
      Molecular Pharmacology May 1990, 37 (5) 631-638;
  2. Javitt, D C

    1. You have access
      Rat brain N-methyl-D-aspartate receptors require multiple molecules of agonist for activation.
      D C Javitt, M J Frusciante and S R Zukin
      Molecular Pharmacology May 1990, 37 (5) 603-607;
  3. Jørgensen, N

    1. You have access
      Valproate and palmitate binding to human serum albumin: an hypothesis on obesity.
      R Brodersen, N Jørgensen, H Vorum and N Krukow
      Molecular Pharmacology May 1990, 37 (5) 704-709;

K

  1. Krukow, N

    1. You have access
      Valproate and palmitate binding to human serum albumin: an hypothesis on obesity.
      R Brodersen, N Jørgensen, H Vorum and N Krukow
      Molecular Pharmacology May 1990, 37 (5) 704-709;

L

  1. Landry, Y

    1. You have access
      Sialic acid residues as catalysts for M2-muscarinic agonist-receptor interactions.
      E B Haddad, Y Landry and J P Gies
      Molecular Pharmacology May 1990, 37 (5) 682-688;
  2. Law, S F

    1. You have access
      Solubilization of active somatostatin receptors from rat brain.
      H T He, S Rens-Domiano, J M Martin, S F Law, S Borislow, M Woolkalis, D Manning and T Reisine
      Molecular Pharmacology May 1990, 37 (5) 614-621;
  3. Lim, I

    1. You have access
      Stereoselective sulfoxidation of a series of alkyl p-tolyl sulfides by microsomal and purified flavin-containing monooxygenases.
      A E Rettie, B D Bogucki, I Lim and G P Meier
      Molecular Pharmacology May 1990, 37 (5) 643-651;

M

  1. Magnan, J

    1. You have access
      Quantitative analysis of multiple kappa-opioid receptors by selective and nonselective ligand binding in guinea pig spinal cord: resolution of high and low affinity states of the kappa 2 receptors by a computerized model-fitting technique.
      M Tiberi and J Magnan
      Molecular Pharmacology May 1990, 37 (5) 694-703;
  2. Manning, D

    1. You have access
      Solubilization of active somatostatin receptors from rat brain.
      H T He, S Rens-Domiano, J M Martin, S F Law, S Borislow, M Woolkalis, D Manning and T Reisine
      Molecular Pharmacology May 1990, 37 (5) 614-621;
  3. Mansour, T E

    1. You have access
      Serotonin receptor-mediated activation of adenylate cyclase in the neuroblastoma NCB.20: a novel 5-hydroxytryptamine receptor.
      D A Conner and T E Mansour
      Molecular Pharmacology May 1990, 37 (5) 742-751;
  4. Martin, J M

    1. You have access
      Solubilization of active somatostatin receptors from rat brain.
      H T He, S Rens-Domiano, J M Martin, S F Law, S Borislow, M Woolkalis, D Manning and T Reisine
      Molecular Pharmacology May 1990, 37 (5) 614-621;
  5. Mason, S R

    1. You have access
      Cytochrome P450IIIA enzymes in rat liver microsomes: involvement in C3-hydroxylation of diazepam and nordazepam but not N-dealkylation of diazepam and temazepam.
      P E Reilly, D A Thompson, S R Mason and W D Hooper
      Molecular Pharmacology May 1990, 37 (5) 767-774;
  6. Maurice, D H

    1. You have access
      Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
      D H Maurice and R J Haslam
      Molecular Pharmacology May 1990, 37 (5) 671-681;
  7. Meier, G P

    1. You have access
      Stereoselective sulfoxidation of a series of alkyl p-tolyl sulfides by microsomal and purified flavin-containing monooxygenases.
      A E Rettie, B D Bogucki, I Lim and G P Meier
      Molecular Pharmacology May 1990, 37 (5) 643-651;
  8. Merta, A

    1. You have access
      Mechanism of action of 5-(2-chloroethyl)-2'-deoxyuridine, a selective inhibitor of herpes simplex virus replication.
      E De Clercq, R Bernaerts, A Merta and B Rosenwirth
      Molecular Pharmacology May 1990, 37 (5) 658-664;
  9. Mölders, H

    1. You have access
      Stable expression of rat cytochrome P-450IA1 cDNA in V79 Chinese hamster cells and their use in mutagenicity testing.
      S Dogra, J Doehmer, H Glatt, H Mölders, P Siegert, T Friedberg, A Seidel and F Oesch
      Molecular Pharmacology May 1990, 37 (5) 608-613;
  10. Molinoff, P B

    1. You have access
      Serotonin-2 receptors coupled to phosphoinositide hydrolysis in a clonal cell line.
      K J Ivins and P B Molinoff
      Molecular Pharmacology May 1990, 37 (5) 622-630;
  11. Müller, U

    1. You have access
      Pseudomonas exotoxin A prevents beta-adrenoceptor-induced upregulation of Gi protein alpha-subunits and adenylyl cyclase desensitization in rat heart muscle cells.
      C Reithmann, P Gierschik, U Müller, K Werdan and K H Jakobs
      Molecular Pharmacology May 1990, 37 (5) 631-638;

N

  1. Nicoletti, F

    1. You have access
      Specific binding sites for inositolhexakisphosphate in brain and anterior pituitary.
      F Nicoletti, V Bruno, S Cavallaro, A Copani, M A Sortino and P L Canonico
      Molecular Pharmacology May 1990, 37 (5) 689-693;

O

  1. Oesch, F

    1. You have access
      Stable expression of rat cytochrome P-450IA1 cDNA in V79 Chinese hamster cells and their use in mutagenicity testing.
      S Dogra, J Doehmer, H Glatt, H Mölders, P Siegert, T Friedberg, A Seidel and F Oesch
      Molecular Pharmacology May 1990, 37 (5) 608-613;

R

  1. Reilly, P E

    1. You have access
      Cytochrome P450IIIA enzymes in rat liver microsomes: involvement in C3-hydroxylation of diazepam and nordazepam but not N-dealkylation of diazepam and temazepam.
      P E Reilly, D A Thompson, S R Mason and W D Hooper
      Molecular Pharmacology May 1990, 37 (5) 767-774;
  2. Reisine, T

    1. You have access
      Solubilization of active somatostatin receptors from rat brain.
      H T He, S Rens-Domiano, J M Martin, S F Law, S Borislow, M Woolkalis, D Manning and T Reisine
      Molecular Pharmacology May 1990, 37 (5) 614-621;
  3. Reithmann, C

    1. You have access
      Pseudomonas exotoxin A prevents beta-adrenoceptor-induced upregulation of Gi protein alpha-subunits and adenylyl cyclase desensitization in rat heart muscle cells.
      C Reithmann, P Gierschik, U Müller, K Werdan and K H Jakobs
      Molecular Pharmacology May 1990, 37 (5) 631-638;
  4. Relling, M V

    1. You have access
      Xbal 16- plus 9-kilobase DNA restriction fragments identify a mutant allele for debrisoquin hydroxylase: report of a family study.
      W E Evans and M V Relling
      Molecular Pharmacology May 1990, 37 (5) 639-642;
  5. Rens-Domiano, S

    1. You have access
      Solubilization of active somatostatin receptors from rat brain.
      H T He, S Rens-Domiano, J M Martin, S F Law, S Borislow, M Woolkalis, D Manning and T Reisine
      Molecular Pharmacology May 1990, 37 (5) 614-621;
  6. Rettie, A E

    1. You have access
      Stereoselective sulfoxidation of a series of alkyl p-tolyl sulfides by microsomal and purified flavin-containing monooxygenases.
      A E Rettie, B D Bogucki, I Lim and G P Meier
      Molecular Pharmacology May 1990, 37 (5) 643-651;
  7. Roca, D J

    1. You have access
      gamma-Aminobutyric acidA receptor regulation in culture: altered allosteric interactions following prolonged exposure to benzodiazepines, barbiturates, and methylxanthines.
      D J Roca, G D Schiller, L Friedman, I Rozenberg, T T Gibbs and D H Farb
      Molecular Pharmacology May 1990, 37 (5) 710-719;
  8. Rosenwirth, B

    1. You have access
      Mechanism of action of 5-(2-chloroethyl)-2'-deoxyuridine, a selective inhibitor of herpes simplex virus replication.
      E De Clercq, R Bernaerts, A Merta and B Rosenwirth
      Molecular Pharmacology May 1990, 37 (5) 658-664;
  9. Rozenberg, I

    1. You have access
      gamma-Aminobutyric acidA receptor regulation in culture: altered allosteric interactions following prolonged exposure to benzodiazepines, barbiturates, and methylxanthines.
      D J Roca, G D Schiller, L Friedman, I Rozenberg, T T Gibbs and D H Farb
      Molecular Pharmacology May 1990, 37 (5) 710-719;

S

  1. Saito, N

    1. You have access
      Differential expression of gamma-aminobutyric acidA receptor subunits.
      K M Garrett, N Saito, R S Duman, M S Abel, R A Ashton, S Fujimori, B Beer, J F Tallman, M P Vitek and A J Blume
      Molecular Pharmacology May 1990, 37 (5) 652-657;
  2. Schiller, G D

    1. You have access
      gamma-Aminobutyric acidA receptor regulation in culture: altered allosteric interactions following prolonged exposure to benzodiazepines, barbiturates, and methylxanthines.
      D J Roca, G D Schiller, L Friedman, I Rozenberg, T T Gibbs and D H Farb
      Molecular Pharmacology May 1990, 37 (5) 710-719;
  3. Schonbrunn, A

    1. You have access
      Desensitization of islet cells to bombesin involves both receptor down-modulation and inhibition of receptor function.
      S L Swope and A Schonbrunn
      Molecular Pharmacology May 1990, 37 (5) 758-766;
  4. Seidel, A

    1. You have access
      Stable expression of rat cytochrome P-450IA1 cDNA in V79 Chinese hamster cells and their use in mutagenicity testing.
      S Dogra, J Doehmer, H Glatt, H Mölders, P Siegert, T Friedberg, A Seidel and F Oesch
      Molecular Pharmacology May 1990, 37 (5) 608-613;
  5. Sharma, V K

    1. You have access
      Antipsychotic pimozide is a potent Ca2+ channel blocker in heart.
      J J Enyeart, R T Dirksen, V K Sharma, D J Williford and S S Sheu
      Molecular Pharmacology May 1990, 37 (5) 752-757;
  6. Sheu, S S

    1. You have access
      Antipsychotic pimozide is a potent Ca2+ channel blocker in heart.
      J J Enyeart, R T Dirksen, V K Sharma, D J Williford and S S Sheu
      Molecular Pharmacology May 1990, 37 (5) 752-757;
  7. Siegert, P

    1. You have access
      Stable expression of rat cytochrome P-450IA1 cDNA in V79 Chinese hamster cells and their use in mutagenicity testing.
      S Dogra, J Doehmer, H Glatt, H Mölders, P Siegert, T Friedberg, A Seidel and F Oesch
      Molecular Pharmacology May 1990, 37 (5) 608-613;
  8. Sortino, M A

    1. You have access
      Specific binding sites for inositolhexakisphosphate in brain and anterior pituitary.
      F Nicoletti, V Bruno, S Cavallaro, A Copani, M A Sortino and P L Canonico
      Molecular Pharmacology May 1990, 37 (5) 689-693;
  9. Swope, S L

    1. You have access
      Desensitization of islet cells to bombesin involves both receptor down-modulation and inhibition of receptor function.
      S L Swope and A Schonbrunn
      Molecular Pharmacology May 1990, 37 (5) 758-766;

T

  1. Tallman, J F

    1. You have access
      Differential expression of gamma-aminobutyric acidA receptor subunits.
      K M Garrett, N Saito, R S Duman, M S Abel, R A Ashton, S Fujimori, B Beer, J F Tallman, M P Vitek and A J Blume
      Molecular Pharmacology May 1990, 37 (5) 652-657;
  2. Thompson, D A

    1. You have access
      Cytochrome P450IIIA enzymes in rat liver microsomes: involvement in C3-hydroxylation of diazepam and nordazepam but not N-dealkylation of diazepam and temazepam.
      P E Reilly, D A Thompson, S R Mason and W D Hooper
      Molecular Pharmacology May 1990, 37 (5) 767-774;
  3. Tiberi, M

    1. You have access
      Quantitative analysis of multiple kappa-opioid receptors by selective and nonselective ligand binding in guinea pig spinal cord: resolution of high and low affinity states of the kappa 2 receptors by a computerized model-fitting technique.
      M Tiberi and J Magnan
      Molecular Pharmacology May 1990, 37 (5) 694-703;

V

  1. Vitek, M P

    1. You have access
      Differential expression of gamma-aminobutyric acidA receptor subunits.
      K M Garrett, N Saito, R S Duman, M S Abel, R A Ashton, S Fujimori, B Beer, J F Tallman, M P Vitek and A J Blume
      Molecular Pharmacology May 1990, 37 (5) 652-657;
  2. Vorum, H

    1. You have access
      Valproate and palmitate binding to human serum albumin: an hypothesis on obesity.
      R Brodersen, N Jørgensen, H Vorum and N Krukow
      Molecular Pharmacology May 1990, 37 (5) 704-709;

W

  1. Werdan, K

    1. You have access
      Pseudomonas exotoxin A prevents beta-adrenoceptor-induced upregulation of Gi protein alpha-subunits and adenylyl cyclase desensitization in rat heart muscle cells.
      C Reithmann, P Gierschik, U Müller, K Werdan and K H Jakobs
      Molecular Pharmacology May 1990, 37 (5) 631-638;
  2. White, M M

    1. You have access
      Niflumic and flufenamic acids are potent reversible blockers of Ca2(+)-activated Cl- channels in Xenopus oocytes.
      M M White and M Aylwin
      Molecular Pharmacology May 1990, 37 (5) 720-724;
  3. Williford, D J

    1. You have access
      Antipsychotic pimozide is a potent Ca2+ channel blocker in heart.
      J J Enyeart, R T Dirksen, V K Sharma, D J Williford and S S Sheu
      Molecular Pharmacology May 1990, 37 (5) 752-757;
  4. Woolkalis, M

    1. You have access
      Solubilization of active somatostatin receptors from rat brain.
      H T He, S Rens-Domiano, J M Martin, S F Law, S Borislow, M Woolkalis, D Manning and T Reisine
      Molecular Pharmacology May 1990, 37 (5) 614-621;
  5. Wu, F S

    1. You have access
      Inverse modulation of gamma-aminobutyric acid- and glycine-induced currents by progesterone.
      F S Wu, T T Gibbs and D H Farb
      Molecular Pharmacology May 1990, 37 (5) 597-602;

Z

  1. Zukin, S R

    1. You have access
      Rat brain N-methyl-D-aspartate receptors require multiple molecules of agonist for activation.
      D C Javitt, M J Frusciante and S R Zukin
      Molecular Pharmacology May 1990, 37 (5) 603-607;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 37, Issue 5
1 May 1990
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics